Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00669994 · ClinicalTrials.gov registry record · Phase 4

Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections

A Phase 4 study of Urinary Tract Infection, sponsored by Bayer.

Completed
Registry status
Phase 4
Development phase
180
Enrollment target
20
Study locations

NCT00669994 is a Phase 4 study of Urinary Tract Infection that has completed, run by Bayer. The registered enrollment target is 180 participants, below the 657-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (73% lower). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00669994, a Phase 4 study of Urinary Tract Infection, has completed, sponsored by Bayer.

COMPLETED
Registry status
Phase 4
Development phase
180 participants
Enrollment target
20
Study locations

Study Summary

This trial evaluated how effective and safe Cipro XR was in treating female patients with signs and symptoms of a lower urinary tract infections. After 3 days of treatment, patients were evaluated to determine if signs/symptoms disappeared and the infecting bacteria was eliminated.

Conditions Studied

Urinary Tract Infection

Interventions

  • DRUG Ciprofloxacin

Study Locations (20)

California

  • - Laguna Hills
  • - Long Beach
  • - San Diego
  • - San Luis Obispo
  • - San Mateo
  • - Sylmar
  • - Yorba Linda

Alabama

  • - Birmingham
  • - Birmingham
  • - Pelham

Florida

  • - Clearwater
  • - Pembroke Pines

New Jersey

  • - Elizabeth
  • - Holmdel

Arizona

  • - Phoenix

Connecticut

  • - Avon

Indiana

  • - Evansville

Massachusetts

  • - Milford

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2003-07
Est. Completion 2003-10
Phase Phase 4

Sponsor

Bayer

591 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00669994

The ClinicalTrials.gov registry entry for NCT00669994 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 657-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (73% lower). The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Urinary Tract Infection appearing as the primary indexed condition, and to 1 intervention - of which Ciprofloxacin is the first listed.

NCT00669994 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Alabama, Florida.

Frequently Asked Questions

What is clinical trial NCT00669994 about?

NCT00669994 is a clinical study titled "Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections". This trial evaluated how effective and safe Cipro XR was in treating female patients with signs and symptoms of a lower urinary tract infections. After 3 days of treatment, patients were evaluated to determine if signs/symptoms disappeared and the infecting bacteria was eliminated.

What is the current status of trial NCT00669994?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 2003-07. Estimated completion is 2003-10.

What conditions does trial NCT00669994 study?

This clinical trial studies the following conditions: Urinary Tract Infection.

What interventions are being tested in trial NCT00669994?

The interventions under investigation include: Ciprofloxacin (DRUG).

Who is sponsoring clinical trial NCT00669994?

This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00669994 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Urinary Tract Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Urinary Tract Infection

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.